1. Home
  2. JNVR vs CHEK Comparison

JNVR vs CHEK Comparison

Compare JNVR & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JNVR
  • CHEK
  • Stock Information
  • Founded
  • JNVR 2018
  • CHEK 2004
  • Country
  • JNVR United States
  • CHEK Israel
  • Employees
  • JNVR N/A
  • CHEK N/A
  • Industry
  • JNVR Finance: Consumer Services
  • CHEK Medical Electronics
  • Sector
  • JNVR Finance
  • CHEK Health Care
  • Exchange
  • JNVR Nasdaq
  • CHEK Nasdaq
  • Market Cap
  • JNVR 7.0M
  • CHEK 9.0M
  • IPO Year
  • JNVR 2023
  • CHEK 2015
  • Fundamental
  • Price
  • JNVR $4.80
  • CHEK $0.80
  • Analyst Decision
  • JNVR
  • CHEK
  • Analyst Count
  • JNVR 0
  • CHEK 0
  • Target Price
  • JNVR N/A
  • CHEK N/A
  • AVG Volume (30 Days)
  • JNVR 9.7K
  • CHEK 71.8K
  • Earning Date
  • JNVR 03-27-2025
  • CHEK 03-04-2025
  • Dividend Yield
  • JNVR N/A
  • CHEK N/A
  • EPS Growth
  • JNVR N/A
  • CHEK N/A
  • EPS
  • JNVR N/A
  • CHEK N/A
  • Revenue
  • JNVR $1,820,969.00
  • CHEK N/A
  • Revenue This Year
  • JNVR N/A
  • CHEK N/A
  • Revenue Next Year
  • JNVR N/A
  • CHEK N/A
  • P/E Ratio
  • JNVR N/A
  • CHEK N/A
  • Revenue Growth
  • JNVR N/A
  • CHEK N/A
  • 52 Week Low
  • JNVR $3.37
  • CHEK $0.56
  • 52 Week High
  • JNVR $11.84
  • CHEK $3.45
  • Technical
  • Relative Strength Index (RSI)
  • JNVR 41.53
  • CHEK 39.16
  • Support Level
  • JNVR $4.91
  • CHEK $0.81
  • Resistance Level
  • JNVR $5.35
  • CHEK $0.92
  • Average True Range (ATR)
  • JNVR 0.39
  • CHEK 0.09
  • MACD
  • JNVR -0.07
  • CHEK -0.01
  • Stochastic Oscillator
  • JNVR 0.00
  • CHEK 0.00

About JNVR Janover Inc.

Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: